KCT0002232已完成未知
Effects of daily tadalafil 5mg administration on post-voided dribbling (PVD) in men with lower urinary tract symptoms: A Prospective, Multicenter, Double-blind, Placebo-Controlled, Randomized Clinical Study
Hallym University Medical Center- Chuncheon0 个研究点目标入组 102 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 102
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional Study
入排标准
- 年龄范围
- 20(Year) 至 69(Year)（—）
- 性别
- Male
入选标准
- •1. 20 = age < 70
- •2. intenational prostate symptome score >8
- •3. Hallym post voided dribbling questionnaire >1
- •4. He must have a sexual partner and have a sexual relationship more than two per a month
- •5. He voluntarily participated in this study
排除标准
- •(1) stroke, myocardial infarction,Coronary artery bypass graft surgery history with in 6 months
- •(2) cardiac failure, unstable angina, life-threatening arrhythmia with in 6 months
- •(3) uncontrolled Diabetes mellitus (HbA1C > 12%)
- •(4) proliferative diabetic retinopathy
- •(5) Spinal injury, pelvic surgery history
- •(6) lower blood pressure thant 90/50mmHg, higher blood pressure more than170/100mmHg
- •(7) penile curvature, urethral stricture, Pyeronie's disease
- •(8) abnormal liver or renal function
- •(9)retinitis pigmentosa
- •(10) active peptic ulceration within 1 year
- •(11) Obvious candidate of Priapism (leukemia..)
- •(12) congenital QT prolongation syndrome patinet, drug medication with prolonged QT interval
- •(13) psychotic disorder
- •(14) Nitrates/Nitric oxide(NO) donor(ex. nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, amyl nitrate/nitrite, Sodium nitroprusside)
- •(15)cancer chemotherapy
- •(16) anticoagulants medication
- •(17) affect for metabolism CYP3A4
- •(18) other phosphodiesterase-5 (PDE5) inhibitor medication within 2 weeks
- •(19) other Randomized Clinical Trial participants
- •(20) hypersensitivity history associated with phosphodiesterase-5 (PDE5) inhibitor
研究者
相似试验
尚未招募
不适用
The effect of tadalafil on spinal cord injury patientsIRCT20220623055260N1Mashhad University of Medical Sciences12
进行中（未招募）
1 期
Impact of Tadalafil (LY450190) Once a Day or Tadalafil On Demand Compared to Sildenafil Citrate On Demand on Treatment Discontinuation in Patients with Erectile Dysfunction who are Naïve to PDE5 InhibitorsMedDRA version: 12.1Level: LLTClassification code 10061461Term: Erectile dysfunctionErectile DysfunctionEUCTR2009-011318-22-FREli Lilly and Company Limited
进行中（未招募）
不适用
Impact of Tadalafil (LY450190) Once a Day or Tadalafil On Demand Compared to Sildenafil Citrate On Demand on Treatment Discontinuation in Patients with Erectile Dysfunction who are Naïve to PDE5 Inhibitors - LVIJMedDRA version: 14.0Level: PTClassification code 10061461Term: Erectile dysfunctionSystem Organ Class: 10038604 - Reproductive system and breast disordersErectile DysfunctionEUCTR2009-011318-22-DEEli Lilly and Company Limited700
进行中（未招募）
不适用
Impact of Tadalafil (LY450190) Once a Day or Tadalafil On Demand Compared to Sildenafil Citrate On Demand on Treatment Discontinuation in Patients with Erectile Dysfunction who are Naïve to PDE5 Inhibitors - LVIJErectile DysfunctionEUCTR2009-011318-22-GREli Lilly and Company Limited700
进行中（未招募）
不适用
Impact of Tadalafil (LY450190) Once a Day or Tadalafil On Demand Compared to Sildenafil Citrate On Demand on Treatment Discontinuation in Patients with Erectile Dysfunction who are Naïve to PDE5 Inhibitors - LVIJMedDRA version: 12.1Level: LLTClassification code 10061461Term: Erectile dysfunctionErectile DysfunctionEUCTR2009-011318-22-PTEli Lilly and Company Limited700